Cullen Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273M Sell
1,114,929
-44,117
-4% -$10.3M 2.79% 3
2025
Q4
$240M Sell
1,159,046
-36,315
-3% -$7.18M 2.62% 8
2025
Q3
$222M Sell
1,195,361
-16,256
-1% -$2.79M 2.42% 11
2025
Q2
$185M Sell
1,211,617
-23,269
-2% -$3.58M 2.11% 18
2025
Q1
$205M Buy
1,234,886
+54,904
+5% +$8.59M 2.37% 16
2024
Q4
$171M Sell
1,179,982
-54,495
-4% -$8.44M 1.99% 24
2024
Q3
$200M Buy
1,234,477
+21,508
+2% +$3.43M 2.18% 22
2024
Q2
$177M Sell
1,212,969
-47,760
-4% -$7.1M 2.04% 22
2024
Q1
$199M Buy
1,260,729
+342,730
+37% +$54.6M 2.22% 20
2023
Q4
$144M Sell
917,999
-449,773
-33% -$69M 2.13% 20
2023
Q3
$213M Sell
1,367,772
-295,938
-18% -$48.8M 2.49% 15
2023
Q2
$275M Buy
1,663,710
+18,238
+1% +$2.94M 2.46% 6
2023
Q1
$255M Buy
1,645,472
+406,484
+33% +$65.6M 2.33% 10
2022
Q4
$219M Sell
1,238,988
-388,232
-24% -$67M 2.81% 3
2022
Q3
$266M Buy
1,627,220
+266,074
+20% +$45M 2.85% 1
2022
Q2
$242M Sell
1,361,146
-14,637
-1% -$2.61M 2.43% 6
2022
Q1
$244M Buy
1,375,783
+74,457
+6% +$12.7M 2.24% 9
2021
Q4
$223M Sell
1,301,326
-39,882
-3% -$6.53M 2.09% 13
2021
Q3
$217M Buy
1,341,208
+10,294
+0.8% +$1.76M 2.13% 11
2021
Q2
$219M Buy
1,330,914
+101,166
+8% +$16.7M 2.12% 11
2021
Q1
$202M Buy
1,229,748
+897,118
+270% +$145M 2.18% 10
2020
Q4
$52.3M Sell
332,630
-69,290
-17% -$10.2M 2.91% 3
2020
Q3
$59.8M Buy
401,920
+2,035
+0.5% +$301K 3.47% 1
2020
Q2
$56.2M Sell
399,885
-69,055
-15% -$10.1M 3.16% 4
2020
Q1
$61.5M Sell
468,940
-58,285
-11% -$8.27M 3.55% 4
2019
Q4
$76.9M Buy
527,225
+7,625
+1% +$1.03M 3.02% 4
2019
Q3
$67.2M Buy
519,600
+1,805
+0.3% +$238K 2.7% 9
2019
Q2
$72.1M Sell
517,795
-1,835
-0.4% -$254K 2.82% 9
2019
Q1
$72.6M Buy
519,630
+5,500
+1% +$737K 2.87% 7
2018
Q4
$66.3M Sell
514,130
-40,240
-7% -$5.61M 2.86% 8
2018
Q3
$76.6M Sell
554,370
-5,170
-0.9% -$687K 2.82% 4
2018
Q2
$67.9M Buy
559,540
+2,205
+0.4% +$275K 2.57% 10
2018
Q1
$71.4M Buy
557,335
+4,125
+0.7% +$558K 2.53% 9
2017
Q4
$77.3M Sell
553,210
-84,740
-13% -$11.8M 2.65% 5
2017
Q3
$82.9M Buy
637,950
+1,280
+0.2% +$170K 2.89% 3
2017
Q2
$84.2M Sell
636,670
-33,172
-5% -$4.23M 2.96% 5
2017
Q1
$83.4M Sell
669,842
-28,788
-4% -$3.44M 2.93% 5
2016
Q4
$80.5M Sell
698,630
-95,075
-12% -$11M 2.78% 9
2016
Q3
$93.8M Sell
793,705
-34,040
-4% -$4.13M 3.17% 4
2016
Q2
$100M Sell
827,745
-80,335
-9% -$9.13M 3.54% 3
2016
Q1
$98.3M Sell
908,080
-95,970
-10% -$9.94M 3.48% 2
2015
Q4
$103M Sell
1,004,050
-79,620
-7% -$8.01M 3.48% 2
2015
Q3
$101M Buy
1,083,670
+50
+0% +$4.84K 3.55% 2
2015
Q2
$106M Sell
1,083,620
-2,550
-0.2% -$255K 3.37% 3
2015
Q1
$109M Sell
1,086,170
-750
-0.1% -$76.3K 3.06% 10
2014
Q4
$114M Sell
1,086,920
-81,950
-7% -$8.64M 3.09% 6
2014
Q3
$125M Buy
1,168,870
+650
+0.1% +$67.4K 3.42% 3
2014
Q2
$122M Buy
1,168,220
+200
+0% +$20.2K 3.17% 7
2014
Q1
$115M Sell
1,168,020
-54,210
-4% -$5.03M 3.1% 7
2013
Q4
$112M Buy
1,222,230
+14,550
+1% +$1.34M 2.94% 8
2013
Q3
$105M Buy
1,207,680
+15,640
+1% +$1.4M 2.97% 7
2013
Q2
$102M Buy
+1,192,040
New +$101M 3.11% 5

Other funds holding JNJ

Cullen Capital Management's JNJ Position: Q1 2026 in Review

Cullen Capital Management reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q1 2026, selling an estimated $10.3M and leaving 1,114,929 shares worth $273M. The position accounts for 2.79% of the portfolio, ranked #3.

Cullen Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $275M in Q2 2023. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cullen Capital Management held 1,114,929 shares of Johnson & Johnson worth $273M as of Q1 2026.
  • Cullen Capital Management sold 44,117 Johnson & Johnson shares in Q1 2026, an estimated $10.3M.
  • Johnson & Johnson made up 2.79% of Cullen Capital Management's portfolio in Q1 2026, its #3 holding.
  • Cullen Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Cullen Capital Management's Johnson & Johnson position peaked at $275M in Q2 2023.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cullen Capital Management's 13F filing for Q1 2026, filed 15 May 2026.